{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544419119957504.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1124/jpet.102.044271"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524362925?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524362925?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1124/jpet.102.044271"}}],"dc:title":[{"@value":"Role of Cytochrome P4501B1 in Benzo[a]pyrene Bioactivation to DNA-Binding Metabolites in Mouse Vascular Smooth Muscle Cells: Evidence from 32P-Postlabeling for Formation of 3-Hydroxybenzo[a]pyrene and Benzo[a]pyrene-3,6-quinone as Major Proximate Genotoxic Intermediates"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544419119957507","@type":"Researcher","foaf:name":[{"@value":"Bhagavatula Moorthy"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419119957504","@type":"Researcher","foaf:name":[{"@value":"Kimberly P. Miller"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419119957506","@type":"Researcher","foaf:name":[{"@value":"Weiwu Jiang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419119957376","@type":"Researcher","foaf:name":[{"@value":"E. Spencer Williams"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419119957505","@type":"Researcher","foaf:name":[{"@value":"Sudha R. Kondraganti"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544419119957508","@type":"Researcher","foaf:name":[{"@value":"Kenneth S. Ramos"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00223565"}],"prism:publicationName":[{"@value":"The Journal of Pharmacology and Experimental Therapeutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2003-04","prism:volume":"305","prism:number":"1","prism:startingPage":"394","prism:endingPage":"401"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022356524362925?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022356524362925?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1124/jpet.102.044271"}],"createdAt":"2003-03-21","modifiedAt":"2025-02-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/2050025942007636736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Modulation of benzo[a]pyrene–DNA adduct formation by CYP1 inducer and inhibitor"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1124/jpet.102.044271"},{"@type":"CROSSREF","@value":"10.1186/s41021-017-0076-x_references_DOI_VVFyyA4zgwZyupo0F7fiI5FT9xa"}]}